|
English
|
正體中文
|
简体中文
|
2817371
|
|
???header.visitor??? :
27726418
???header.onlineuser??? :
390
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"oh dy oh do youn"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2012-05 |
Phase Ib dose-escalation study of a phase II randomized trial to assess the safety and tolerability of tigatuzumab (CS-1008) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Cheng, AL (Cheng, Ann-Lii); Kang, YK (Kang, Yoon-Koo); Ryoo, BY (Ryoo, Baek-Yeol); Yen, CJ (Yen, Chia-Jui); Lim, HY (Lim, Ho Yeong); Oh, DY (Oh, Do-Youn); Austin, T (Austin, TaShara); Wang, Q (Wang, Qiang); Greenberg, J (Greenberg, Jonathan); Beckman, RA (Beckman, Robert A.); Kudo, M (Kudo, Masatoshi) |
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
